These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14308252)

  • 1. [CLINICAL EXPERIENCES WITH ALPHA-METHYL-DOPA, A DECARBOXYLASE INHIBITOR].
    RIPKA O
    Cas Lek Cesk; 1965 Feb; 104():173-5. PubMed ID: 14308252
    [No Abstract]   [Full Text] [Related]  

  • 2. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 3. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 6. [EFFECT OF ALPHA-METHYLDOPALANINE AND SERYLTRIHYDROXYBENZYLHYDRAZINE (RO 4-4602) ON THE DOPA-DECARBOXYLASE ACTIVITY].
    CHRUSCIEL TL; POJDA SM
    Acta Physiol Pol; 1965; 16():111-5. PubMed ID: 14338596
    [No Abstract]   [Full Text] [Related]  

  • 7. MULTIPLE INHIBITORY EFFECTS OF ALPHA-METHYLAMINO ACIDS ON THE METABOLISM OF C14-LABELED TYROSINE, DOPA AND ALPHA-METHYLDOPA.
    MORAN JF; SOURKES TL
    J Pharmacol Exp Ther; 1965 May; 148():252-61. PubMed ID: 14301016
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON THE STEREOSPECIFICITY OF THE DECARBOXYLASE INHIBITING ACTION OF ALPHA-METHYLDOPA].
    PUETTER J; KRONEBERG G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Nov; 249():470-8. PubMed ID: 14335181
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].
    SCHAER H; ZIEGLER WH
    Klin Wochenschr; 1962 Sep; 40():959-62. PubMed ID: 13976633
    [No Abstract]   [Full Text] [Related]  

  • 11. [DECARBOXYLASE INHIBITORS IN THE THERAPY OF ARTERIAL HYPERTENSION (L-ALPHA-METHYLDOPA)].
    BUONINCONTI R; JACONO A; VITALE P
    Minerva Med; 1963 Oct; 54():3169-74. PubMed ID: 14104505
    [No Abstract]   [Full Text] [Related]  

  • 12. Actions of the decarboxylase inhibitor, alpha-methyl-3,4-dihydroxyphenylalanine, in the dog.
    GOLDBERG LI; DACOSTA FM; OZAKI M
    Nature; 1960 Nov; 188():502-4. PubMed ID: 13706461
    [No Abstract]   [Full Text] [Related]  

  • 13. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
    SOULAIRAC A; SOULAIRAC ML
    C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
    [No Abstract]   [Full Text] [Related]  

  • 14. [METHYLDOPA AND DECARBOXYLASE INHIBITION].
    OFFERHAUS L; MUEHLEN AC; DE VRIES LA
    Ned Tijdschr Geneeskd; 1964 May; 108():966-8. PubMed ID: 14168782
    [No Abstract]   [Full Text] [Related]  

  • 15. INFLUENCE OF METHYL-DOPA ON TRYPTOPHAN-LOADING TESTS IN HYPERTENSIVE PATIENTS.
    CALESNICK B
    Arch Int Pharmacodyn Ther; 1965 Mar; 154():161-70. PubMed ID: 14346404
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECT OF THE DOPA-DECARBOXYLASE INHIBITOR ALPHA-METHYLDOPA ON THE INCORPORATION OF DOPA INTO MELANIN AND PYROCATECHOLAMINE. IN VIVO STUDIES ON MELANOMA MICE WITH TRITIATED DOPA].
    HEMPEL K; DEIMEL M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1963 Nov; 246():203-14. PubMed ID: 14095447
    [No Abstract]   [Full Text] [Related]  

  • 17. INHIBITION OF THE HYDROXYLATION OF TRYPTOPHAN AND PHENYLALANINE BY ALPHA-METHYL-DOPA AND SIMILAR COMPOUNDS.
    BURKARD WP; GEY KF; PLETSCHER A
    Life Sci (1962); 1964 Jan; 3():27-33. PubMed ID: 14112360
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
    Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
    [No Abstract]   [Full Text] [Related]  

  • 19. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.